ARCHIVES

“Spoiled, Petulant Brat”: BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor

This article is from The Cancer Letter archive.

Vol. 39 No. 42 | November 8, 2013

Download PDF Visit The Full Archive

Related Articles

Zwelling Moves to Legacy Community Health

July 19, 2013

Cancer Control Seeks Grant Applications In Three Interventions Areas And In Community Development

September 13, 1974

DRCCA’s New Board Of Scientific Counselors to Meet Sept. 18-19

August 22, 1980

In Appropriations Hearings, Groups Seek NCI Bypass Budget, Differ On CDC Funding.

April 14, 2000

DCPC Board Approves $40 Million In New Concepts, Including Three In Breast Cancer, One In Melanoma

October 12, 1984

Three cancer centers joined the Multiple Myeloma Research Consortium.

September 16, 2005